Analysis of the clinical characteristics and risk factors for dabigatran-induced bleeding in patients with nonvalvular atrial fibrillation
Int. Journal of Clinical Pharmacology and Therapeutics · 01.01.2026 · 64 (01) · 18-27
DOI: 10.5414/cp204807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.01.2026. Verfasst von Xiaojuan Wang und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dabigatran, Atrial Fibrillation, Hemorrhage, Antithrombins.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Wang, X., Wang, X., Li, Y., Yang, Z., & Wu, D. (2026). Analysis of the clinical characteristics and risk factors for dabigatran-induced bleeding in patients with nonvalvular atrial fibrillation. Int. Journal of Clinical Pharmacology and Therapeutics, 64(01), 18-27. https://doi.org/10.5414/cp204807
Vancouver
Wang X, Wang X, Li Y, Yang Z, Wu D. Analysis of the clinical characteristics and risk factors for dabigatran-induced bleeding in patients with nonvalvular atrial fibrillation. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(01):18-27. doi:10.5414/cp204807
BibTeX
@article{Wang2026,
author = {Wang, Xiaojuan and Wang, Xiaoying and Li, Ya and Yang, Zhenfeng and Wu, Dong},
title = {Analysis of the clinical characteristics and risk factors for dabigatran-induced bleeding in patients with nonvalvular atrial fibrillation},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {01},
pages = {18--27},
doi = {10.5414/cp204807}
}
EUVIMED